Generic Biotechnology Drugs Could Win Congressional Approval
She easiest way to get more generic versions of biotechnology (bio-generic) drugs onto the U.S. market would be to pass a law allowing the Food and Drug Administration (FDA) to approve them. The hardest part would then be the need for the FDA to figure out how to structure a sensible approval process.
